WallStreetZenWallStreetZen

NASDAQ: MRM
Medirom Healthcare Technologies Inc Stock

$6.15-0.05 (-0.81%)
Updated Mar 27, 2024
MRM Price
$6.15
Fair Value Price
N/A
Market Cap
$30.03M
52 Week Low
$3.50
52 Week High
$7.40
P/E
-0.12x
P/B
-10.27x
P/S
0.53x
PEG
N/A
Dividend Yield
N/A
Revenue
$49.72M
Earnings
-$173.57k
Gross Margin
25%
Operating Margin
0.12%
Profit Margin
-0.3%
Debt to Equity
-15.62
Operating Cash Flow
-$7M
Beta
0.41
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MRM Overview

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MRM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MRM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MRM is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
MRM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more MRM due diligence checks available for Premium users.

Be the first to know about important MRM news, forecast changes, insider trades & much more!

MRM News

Valuation

MRM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.12x
Industry
41.44x
Market
44.45x

MRM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-10.27x
Industry
12.31x

MRM's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
MRM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MRM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$42.8M
Liabilities
$45.7M
Debt to equity
-15.62
MRM's short-term liabilities ($23.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRM's long-term liabilities ($22.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MRM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
MRM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MRM vs Personal Service Stocks

TickerMarket Cap1d %P/EP/B
MRM$30.03M-0.81%-0.12x-10.27x
RGS$15.68M-3.10%-3.89x-0.47x
TRNR$4.01M-4.11%-0.01x-14.63x
EJH$719.37k+4.76%-0.01x0.01x
WW$144.15M+5.20%-1.25x-0.19x

Medirom Healthcare Technologies Stock FAQ

What is Medirom Healthcare Technologies's quote symbol?

(NASDAQ: MRM) Medirom Healthcare Technologies trades on the NASDAQ under the ticker symbol MRM. Medirom Healthcare Technologies stock quotes can also be displayed as NASDAQ: MRM.

If you're new to stock investing, here's how to buy Medirom Healthcare Technologies stock.

What is the 52 week high and low for Medirom Healthcare Technologies (NASDAQ: MRM)?

(NASDAQ: MRM) Medirom Healthcare Technologies's 52-week high was $7.40, and its 52-week low was $3.50. It is currently -16.89% from its 52-week high and 75.71% from its 52-week low.

How much is Medirom Healthcare Technologies stock worth today?

(NASDAQ: MRM) Medirom Healthcare Technologies currently has 4,882,500 outstanding shares. With Medirom Healthcare Technologies stock trading at $6.15 per share, the total value of Medirom Healthcare Technologies stock (market capitalization) is $30.03M.

Medirom Healthcare Technologies stock was originally listed at a price of $14.85 in Dec 30, 2020. If you had invested in Medirom Healthcare Technologies stock at $14.85, your return over the last 3 years would have been -58.59%, for an annualized return of -25.46% (not including any dividends or dividend reinvestments).

How much is Medirom Healthcare Technologies's stock price per share?

(NASDAQ: MRM) Medirom Healthcare Technologies stock price per share is $6.15 today (as of Mar 27, 2024).

What is Medirom Healthcare Technologies's Market Cap?

(NASDAQ: MRM) Medirom Healthcare Technologies's market cap is $30.03M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Medirom Healthcare Technologies's market cap is calculated by multiplying MRM's current stock price of $6.15 by MRM's total outstanding shares of 4,882,500.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.